Literature DB >> 7103462

Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis.

D A Stevens, P T Vo.   

Abstract

The in vitro interaction of trimethoprim and sulfamethoxazole on clinical isolates of Paracoccidioides brasiliensis was studied. With complete inhibition and a visual endpoint used as the criteria, three of four strains had minimal inhibitory concentrations that indicated resistance to sulfamethoxazole, and all four strains were resistant to trimethoprim. A marked synergism in inhibition was noted with the combination of these drugs against sulfa-resistant strains. A sulfamethoxazole/trimethoprim ratio of 5:1 was the most synergistic. Fifty percent inhibition, determined spectrophotometrically, of the strains could be achieved with sulfamethoxazole alone. In summary, the striking synergy observed suggests that combination chemotherapy with these drugs deserves further study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7103462      PMCID: PMC182028          DOI: 10.1128/AAC.21.5.852

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Disseminated paracoccidioidomycosis (South American blastomycosis) in the United States.

Authors:  H W Murray; M L Littman; R B Roberts
Journal:  Am J Med       Date:  1974-02       Impact factor: 4.965

2.  Sensitivity testing with trimethorpim-sulphamethoxazole.

Authors:  S R Bushby
Journal:  Med J Aust       Date:  1973-06-30       Impact factor: 7.738

3.  Trimethoprim-sulfamethoxazole.

Authors:  R H Rubin; M N Swartz
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

4.  Various regimens of trimethoprim-sulfamethoxazole used in the treatment of gonorrhea.

Authors:  A Lawrence; I Phillips; C Nicol
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

5.  Effects of trimethoprim and sulfisoxazole, alone and in combination, on growth and carriage of Neisseria meningitidis.

Authors:  H A Feldman
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

6.  Growth of Paracoccidioides brasiliensis yeast phase in a chemically defined culture medium.

Authors:  A Restrepo; B E Jiménez
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

7.  Paracoccidioidomycosis, (South American blastomycosis). A study of 39 cases observed in Medellin, Colombia.

Authors:  A Restrepo; M Robledo; F Gutiérrez; M Sanclemente; E Castañeda; G Calle
Journal:  Am J Trop Med Hyg       Date:  1970-01       Impact factor: 2.345

8.  Ketoconazole: a new drug for the treatment of paracoccidioidomycosis.

Authors:  A Restrepo; D A Stevens; I Gómez; E Leiderman; R Angel; J Fuentes; A Arana; G Mejía; A C Vanegas; M Robledo
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

9.  Paracoccidioidomycosis (South American blastomycosis): treatment with miconazole.

Authors:  D A Stevens; A Restrepo-M; A Cortés; J Betancourt; J N Galgiani; I Gómez
Journal:  Am J Trop Med Hyg       Date:  1978-07       Impact factor: 2.345

10.  In vitro susceptibility testing of Paracoccidioides brasiliensis to sulfonamides.

Authors:  A Restrepo; M D Arango
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

View more
  7 in total

1.  In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.

Authors:  Javier Afeltra; Jacques F G M Meis; Roxana G Vitale; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 2.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

3.  Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens.

Authors:  D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Synergy between cilofungin and amphotericin B in a murine model of candidiasis.

Authors:  L H Hanson; A M Perlman; K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 5.  Paracoccidioidomycosis: an update.

Authors:  E Brummer; E Castaneda; A Restrepo
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

6.  Influence of different media, incubation times, and temperatures for determining the MICs of seven antifungal agents against Paracoccidioides brasiliensis by microdilution.

Authors:  R C Cruz; S M C Werneck; C S Oliveira; P C Santos; B M Soares; D A Santos; P S Cisalpino
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

Review 7.  Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?

Authors:  Lívia do Carmo Silva; Amanda Alves de Oliveira; Dienny Rodrigues de Souza; Katheryne Lohany Barros Barbosa; Kleber Santiago Freitas E Silva; Marcos Antonio Batista Carvalho Júnior; Olívia Basso Rocha; Raisa Melo Lima; Thaynara Gonzaga Santos; Célia Maria de Almeida Soares; Maristela Pereira
Journal:  J Fungi (Basel)       Date:  2020-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.